Proteinea

Proteinea is a TechBio startup based in Cairo, Egypt, that focuses on the discovery, engineering, and manufacturing of biotherapeutics.

Founded in 2020, the company integrates artificial intelligence with biotechnology to enhance the development of life-saving therapies. Proteinea has established a presence in key innovation hubs, including Cambridge and Boston in the USA, and Thuwal in Saudi Arabia. The company offers a range of services in the B2B Life Sciences market, including AI-driven protein engineering, therapeutic protein production, and innovative biomanufacturing using mass-reared insect larvae. Proteinea's proprietary technologies, such as the Ankh protein language model and its insect larvae biomanufacturing system, enable efficient and sustainable production of various proteins, including antibiotics and vaccines. With a strong focus on collaboration, Proteinea partners with pharmaceutical companies, biotech firms, and academic institutions to advance drug discovery and development processes.